Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Dino Di Carlo
University of California Los Angeles, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cytovale Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Di Carlo is a Co-Investigator. He is a founder and scientific adviser for the company.
Cancer Cell Mechanical Profiling Analysis
NARRATIVE The ultimate goal of the project is to develop a new technological platform that may provide a more direct assessment of the malignant potential of cancer. This will be achieved by directly measuring cancer cell mechanical properties using some of the state of art nanotechnology and microfluidic technologies. The immediate objective of this R21 application is to obtain preliminary yet important data for studying mechanotypic marker in cancer diagnosis and prognostic determination in the future prospective randomized control study.
Filed on November 13, 2017.
Tell us what you know about Dino Di Carlo's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Dino Di Carlo”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | VORTEX BIOSCIENCES, INC. | $10,000 - $19,999 |
| Dino Di Carlo | University of California Los Angeles | Financial Disclosure | Vortex Biosciences | |
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | Cytovale Inc. | Value cannot be readily determined |
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | VORTEX BIOSCIENCES, INC. | Value cannot be readily determined |
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | Value cannot be readily determined |
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | VORTEX BIOSCIENCES, INC. | $10,000 - $19,999 |
| Dino Di Carlo | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | $0 - $4,999 |
| Dino Di Carlo | University of California Los Angeles | Financial Disclosure | Vortex Biosciences |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.